The impact of oleanolic and ursolic acid on corneal epithelial cells in vitro by Matysik-Woźniak, Anna et al.
ORIGINAL PAPER
DOI: 10.5603/OJ.2016.0024
124 Copyright © 2016 Via Medica, ISSN 2450–7873
Corresponding author: 
Roman Paduch, PhD, Department of Virology and Immunology, Maria Curie-Skłodowska University, Akademicka 19 St., 20–033 Lublin, Poland,  
tel. +48 81 537 59 44, e-mail: rpaduch@poczta.umcs.lublin.pl
The impact of oleanolic and ursolic acid on 
corneal epithelial cells in vitro
Anna Matysik-Woźniak1, roman paduch1, 2, ryszard Maciejewski3, anselm g. Jünemann4, robert rejdak1, 5
1Department of General Ophthalmology, Medical University of Lublin, Lublin, Poland
2Department of Virology and Immunology, Institute of Microbiology and Biotechnology, Maria Curie-Skłodowska University, Lublin, Poland
3Department of Human Anatomy, Medical University of Lublin, Lublin, Poland
4University Eye Hospital, Rostock, Germany
5Medical Research Centre, Polish Academy of Science, Warsaw, Poland
aBstraCt
introduCtion. Oleanolic (OA) and ursolic (UA) acids belong to the triterpene group widely present in plants. These 
compounds are recognised to have anti-inflammatory properties and thus are considered to be used in therapies as 
well as in cosmetic, natural health, or diet products. 
aiM. The scientific hypothesis of our study was to show that OA and UA influence corneal epithelial cells cultured 
in vitro.
Methods. Toxicity tests, based on MTT and Neutral Red (NR) uptake, measurement of nitric oxide (NOx) level, 
as well as analysis of metalloproteinases (MMP-2 and MMP-9) amount and activity were performed.
resuLts. UA expressed significantly higher toxicity on cells than OA. At the lowest concentration applied (5 µM), 
UA limited cellular metabolism and viability on average by 22% as compared to untreated control, while 25 µM 
resulted in values lower than 10%. On the other hand, OA at the highest (100 µM) concentration limited cellu-
lar metabolism and viability by about 20%. NOx level significantly increased when OA and UA were applied at 
concentrations of 25 and 100 µM, respectively. OA and UA had a stronger impact on the level of MMP-2 than 
MMP-9. OA and UA reduced MMP-2 and MMP-9 in the whole range of concentrations. Tested triterpenoids had 
no significant impact on MMP activity. 
ConCLusions. OA and UA have a different impact on human corneal epithelial cells. UA is toxic for corneal 
epithelial cells, while OA exhibits milder activity, which may be useful for further analysis in ocular pharma-
cology. 
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introduCtion
Oleanolic acid (OA) and ursolic acid (UA) be-
long to the group of ubiquitous pentacyclic trit-
erpenes, which are widely found in herbs, other 
medicinal plants, and food. These compounds exert 
many biological activities such as anti-inflammato-
ry, anticancer, antioxidant, and antiallergic [1, 2]. 
In view of a wide variety of activities, they were also 
considered as suitable in ophthalmology in order 
to protect the eye surface against adverse effects of 
particular inflammations and allergies [1, 3]. Some 
of the factors acting adversely may include matrix 
metalloproteinases (MMPs) or high levels of nitric 
oxide (NO). 
MMPs are a family of proteinases extracellular 
matrix (ECM) both in physiological processes ena-
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bling tissue remodelling or its normal functioning, 
and in pathological processes leading to inflam-
mation, tissue destruction or, in the case of can-
cer, to tumour invasion and metastasis. Specifically, 
MMP-2 and MMP-9 are gelatinases that degrade 
type IV collagen, the major structural component 
of the ECM [4]. These proteases were found to take 
part in many ocular disorders like retinopathy [5], 
cataract [6], uveitis [7], or generally atopic ocular 
diseases [8]. In turn, local micromolar NO concen-
trations may exert similar effects that are connected 
with inflammation and local tissue destruction. On 
the other hand, nanomolar quantities of NO take 
part in maintaining physiological homeostasis on 
the ocular surface. Generally, NO regulate numer-
ous vascular functions in eye, which in turn have 
a significant impact on proper functioning of other 
ocular tissues [9]. 
The cornea surface is created by non-keratinised 
epithelial cells whose arrangement and stability are 
essential for proper vision. These cells are subjected 
to continuous renewal and any manipulation of this 
process as well as of homeostasis of the corneal layer 
may lead to substantial changes in visual acuity [10]. 
Any substances which are administered to the sur-
face of the eye should be analyzed in terms of their 
impact not only on corneal epithelial cells viability 
but simultaneously on the induction of soluble 
factors release which may exert an adverse effect 
on corneal epithelial layer. Therefore, the influ-
ence of triterpenes on local alteration in MMPs or 
NO levels in the corneal epithelium was analysed 
due to their potential important impact on the 
functionality of this tissue, and consequently on 
proper vision.
In our study we hypothesised that OA or UA are 
compounds that might modify the viability of cor-
neal epithelium and secretion of MMPs and NO by 
these cells in vitro. For this reason, we introduced an 
HCE three-dimensional model (SkinEthic™ from 
Episkin, Lyon, France) to test NOx and MMPs 
quantity and activity, as well as classic two-dimen-
sional cultures of corneal epithelial cells in order 
to demonstrate changes in cell viability after their 
incubation with OA and UA.
MateriaLs and Methods
CeLL CuLtures
Human normal corneal epithelial cell line 
10.014 pRSV-T (ATCC No. CRL-11515) was used. 
The cells were cultured as monolayers in 25-cm2 
culture flasks (Nunc, Roskilde, Denmark) coated 
with PureCol™ ultrapure collagen (INAMED Bi-
omaterials, Fremont, CA) at 3.1 mg/mL concen-
tration. The cell line was maintained in defined 
K-SFM (keratinocyte serum-free medium) (Gib-
co) supplemented with 75 µg/mL endothelial cell 
growth factor (Sigma), 0.05 mg/mL bovine pituitary 
extract (Gibco), 500 ng/mL hydrocortisone (Sigma), 
0.0005 mg/mL bovine insulin (Gibco), and antibi-
otics (100 U/mL penicillin, 100 µg/mL streptomy-
cin) (Sigma, St Louis, MO) at 37°C in a humidified 
atmosphere with 5% CO2. This cell culture was used 
for MTT and NR toxicity tests and MGG staining.
HCE three-dimensional model (SkinEthic™ 
from Episkin, Lyon, France) commercially availa-
ble was also used. This reconstructed HCE model 
consists of immortalised human corneal epithelial 
cells cultured on a chemically-defined permeable 
polycarbonate membrane insert at the air-liquid 
interface. The construct is a multi-layered, stratified 
epithelium similar to that of normal human corneal 
epithelium. This model represents 5–7 viable cell 
layers without significant histological abnormalities 
growing on a 0.5 cm2 surface area. These layers con-
sist of columnar basal cells, transitional wing cells, 
and flattened superficial cells.
The tissues were shipped at room temperature 
in agarose gel that contained medium to preserve 
the quality of the tissues. This agarose-gel was used 
only for transportation, to keep high viability of 
cells. After delivery, the inserts with corneal tis-
sue were immediately transferred to a new 24-well 
culture plate. Thereafter, a liquid-liquid interface 
was performed because a new culture medium was 
added both inside the wells of the 24-well plates 
(medium volume 0.6 mL) as well as inside the 
inserts with cells (medium volume 0.15 mL). Ap-
propriate concentrations (5; 10; 25; 50; 100 µM) 
of oleanolic acid (OA) and ursolic acid (UA) were 
added to the medium present in the insert. 24-well 
plates with inserts were incubated at 37°C, 5% 
CO2 in a humidified incubator. The medium from 
the wells, but not inserts, was collected 24 hours 
later. As a culture medium we used the original 
fluid that was delivered together with cells by the 
manufacturer. This model was used for NOx, MMP, 
and zymography analysis. 
neutraL red (nr) uptaKe assaY
NR cytotoxicity assay analyses the uptake and 
lysosomal accumulation of Neutral Red stain. Cells 
that are damaged do not accumulate the dye. 
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Cells were grown in 96-well multiplates in 100 µL 
of culture medium (K-SFM) with supplements and 
oleanolic acid (OA) (Sigma) or ursolic acid (UA) 
(Sigma) in the concentration range 5–100 µM for 
24 hours. Subsequently, the medium was discarded 
and 0.4% NR (Sigma) solution medium was added 
to each well. The plate was incubated for three hours 
at 37°C in a humidified 5% CO2/95% air incuba-
tor. After incubation, the dye-containing medium 
was removed, cells fixed with 1% CaCl2 in 4% 
paraformaldehyde, and thereafter the incorporated 
dye was solubilised using 1% acetic acetate in 50% 
ethanol solution (100 µL). The plates were gently 
shaken for 20 minutes at room temperature and the 
extracted dye absorbance was measured spectropho-
tometrically at 540 nm using a microplate reader 
(Emax; Molecular Devices Corp., Menlo Park, CA).
Mtt assaY
MTT assay is based on the conversion of yellow 
tetrazolium salt by viable cells to purple formazan 
crystals. Mitochondrial succinate dehydrogenase 
catalyses this reaction.
Cells were grown in 96-well multiplates in 
100 µL of culture medium with OA or UA addition 
at the appropriate concentration (5–100 µM). After 
24 hours of incubation, MTT solution (5 mg/mL, 
25 µL/well) (Sigma) was added, and incubation was 
conducted for a further three hours. The crystals 
of formazan were solubilised overnight in a 10% 
sodium dodecyl sulphate 0.01 M HCl mixture 
(100 µL). The product was quantified spectropho-
tometrically by absorbance measurement at 570 nm 
wavelength using an Emax microplate reader (Mo-
lecular Devices Corp.).
no MeasureMent
Nitrate, a stable end product of NO, was deter-
mined in culture supernatants by a spectrophoto-
metric method based on the Griess reaction. 
Corneal epithelial cells (EpiSkin HCE model) 
were incubated for 24 hors with OA and UA con-
centrations (5; 10; 25; 50; 100 µM). Thereafter, 
culture supernatants were collected. The samples 
were frozen at –80oC and stored for no longer than 
one month. 100 µL of supernatant was plated in 
96-well flat-bottomed plates in triplicate and in-
cubated with 100 µL of Griess reagent (1% sul-
phanilamide/0.1% N-(1-naphthyl)ethylenediamine 
dihydrochloride) (Sigma) in 3% H3PO4 (POCH 
Gliwice, Poland) at room temperature for 10 min-
utes. The optical density was measured at 570 nm 
using a microplate reader (Emax; Molecular De-
vices Corp.). A standard curve was achieved using 
0.5–25 µM sodium nitrite (NaNO2) for calibration 
and quantitative analysis.
MaY-grÜnWaLd-gieMsa (Mgg) staining
Briefly, cells were fixed with methanol for 
10 minutes and stained with May-Grünwald stain 
for three minutes, and diluted in an equal volume of 
distilled water for a further three minutes. The stain 
was removed and Giemsa stain diluted (1:20) in 
water was added for 20 minutes. After that time the 
dye was removed and slides were rinsed three times 
with distilled water, air dried, and observed under 
a light microscope (Olympus BX51).
ZYMographY
MMP activity was measured using SDS-PAGE 
zymography. 
Gelatine (300 µg/mL) (Sigma) was incorporat-
ed into a 7.5% polyacrylamide gel. Culture su-
pernatant samples were mixed with equal volumes 
of 2 × sample buffer (0.25 M Tris-HCl pH 6.8, 
10% (v/v) glycerol, 0.05% (w/v) bromophenol 
blue, and 5% (w/v) SDS) and separated by elec-
trophoresis. The gel was washed in distilled water, 
incubated for one hour at room temperature with 
2.5% (v/v) Triton X-100, washed again in distilled 
water, and incubated for 24 hours at 37°C with de-
veloping buffer (0.05 M Tris-HCl, pH 7.4, 0.01 M 
CaCl2 and 0.02% (w/v) NaN3). After washing, the 
gel was stained for one hour with 0.2% Coomassie 
blue in 50% (v/v) methanol and 10% (v/v) acetic 
acid. Thereafter, the gel was de-stained with 20% 
(v/v) methanol and 10% (v/v) acetic acid. Bands 
of digested substrate indicated metalloproteinase 
activity. 
MMp-2 and MMp-9 eLisa assaY
The levels of MMP-2 and IL-6 were tested im-
munoenzymatically (ELISA) using commercially 
available kits (R&D, Minneapolis, MN, USA), ac-
cording to the manufacturers’ instructions. 
Supernatant samples were added to 96-well mi-
croplates coated with monoclonal antibodies against 
human MMP-2 or MMP-9 and incubated for two 
hours at room temperature. After three washes in 
the appropriate buffer, polyclonal secondary anti-
bodies conjugated to horseradish peroxidase were 
added and incubated for two hours at room temper-
ature. The optical density was measured at 450 nm 
using a microplate reader (Molecular Devices Corp., 
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Figure 1. The effect of 24-hour treatment of human corneal epithelial cells with oleanolic acid (OA) and ursolic acid (UA). MTT assay. 
The results are presented as a percentage of the controls, arbitrarily set to 100%. The figure shows an average of three independent  
experiments. * p ≤ 0.05 — compared with the control
Emax, Menlo Park, CA, USA), and MMP-2 or 
MMP-9 concentrations were calculated from the 
standard curves prepared from recommended sub-
strates. The sensitivity of tests was: 0.082 ng/mL 
for human MMP-2 and 0.156 ng/mL for human 
MMP-9. 
statistiCaL anaLYsis
Results are presented as means ± SD from three 
experiments. Data were analysed using one-way 
ANOVA analysis. Differences of p ≤ 0.05 were con-
sidered significant.
resuLts
Cytotoxic and metabolism changing activity 
(MTT and NR tests).
Oleanolic acid (OA) at concentrations higher 
than 50 µM decreased metabolic activity of corneal 
epithelial cells. At 100 µM of OA applied, it was 
37% ± 7% lower than control. Ursolic acid (UA) 
expressed stronger activity than OA and significant-
ly limited metabolism of cells even at the lowest 
concentration (5 µM) (23% ± 2%) applied as com-
pared to untreated controls. Concentrations of UA 
higher than 25 µM decreased metabolism of corneal 
epithelial cells to the level lower than 10% (Fig. 1).
Similar results were obtained when the cyto-
toxic activity of both compounds was tested using 
NR uptake assay. However, OA significantly de-
creased cell viability only at the highest concentra-
tion (100 µM) (18% ± 3.5%) applied, as compared 
to controls. UA activity coincided with the results 
obtained in MTT test (Fig. 2). 
Staining of cells with May-Grünwald-Giemsa 
(MGG) dye confirmed corneal epithelial cell sen-
sitivity to UA and the low impact of OA on these 
cells (Fig. 3).
nitriC oXide (noX) LeVeL
Control level of NOx produced by corneal ep-
ithelial cells was 0.51 ± 0.01 µM. Both OA and 
UA at concentrations lower than 10 µM had no 
impact on NOx production by corneal epithelial 
cells as compared to controls. Starting form 25 µM 
concentration, UA gradually increased the NOx 
level in culture medium. At the highest concen-
tration used (100 µM) it was 1.93 ± 0.12 µM. On 
the other hand, OA only at the concentration of 
100 µM increased the NOx level to the value of 
0.67 ± 0.01 µM (Fig. 4). 
oa and ua iMpaCt on produCtion oF  
MetaLLoproteinases (MMp-2 and MMp-9) 
Metalloproteinase (MMP-2 and MMP-9) levels 
were tested quantitatively by ELISA, and qualitative 
activity of enzymes was tested by zymography. The 
levels of both enzymes were very low.
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Figure 2. The effect of 24-hour treatment of human corneal epithelial cells with oleanolic acid (OA) and ursolic acid (UA). Neutral Red 
uptake assay. The results are presented as a percentage of the controls, arbitrarily set to 100%. The figure shows an average of three inde-
pendent experiments. * p ≤ 0.05 — compared with the control
Figure 3. May-Grünwald-Giemsa (MGG) staining of corneal (pRSV-T) cells. Control cells (a), cells treated with oleanolic acid (OA)  
(100 µM) (B), and treated with ursolic acid (UA) (100 µM) (C) for 24 hours. Magnification 200 ×. Bar = 20 mm
The control amount of MMP-2 protein was 
0.424 ng/mL. The protein level was decreased 
when the whole range of OA concentrations was 
used. The most significant reductions, about 
three-times as compared to control, were observed 
when low concentrations of terpenes (5–10 µM) 
were applied. UA similarly to OA decreased 
MMP-2 level in a concentration-dependent man-
ner. At the highest concentrations of UA applied 
(50 µM and 100 µM) the decreased protein level 
reached values about 30% lower than those ob-
served in controls (Fig. 5).
MMP-9 control amount was 0.572 ng/ml. Ap-
plication of OA and UA reduced the level of this 
protein. At the lowest concentration (5 µM) OA 
reduced the MMP-2 level by half, while at its high-
est concentration (100 µM) UA reduced this read-
ing to about 40%, as compared to controls (Fig. 6). 
Zymography analysis revealed that enzymatic 
activity could be found only when the highest con-
centration (100 µM) of both OA and UA was used. 
However, it was not possible to find separate bands 
of proteases or their pre-forms, but the whole slots 
after electrophoresis revealed low gelatine proteolyt-
ic activity (Fig. 7). 
disCussion
Natural compounds have been widely used to 
treat different human ailments. Among natural sub-
stances showing activity as health reinforcing stim-
uli, terpenes make up the most important group. 
Oleanolic (OA) and ursolic (UA) acids are members 
of pentacyclic triterpenes and are currently consid-
ered to have possible beneficial effects on ocular 
tissues. These compounds have already been shown 
a B C
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Figure 4. The effect of oleanolic (OA) and ursolic (UA) acid exerted on nitric oxide (NO) (nitrite and nitrate — NOx) secretion from human 
corneal epithelium in vitro. Incubation time — 24 hours. The results are presented as mean ± SD of three independent experiments.  
* p ≤ 0.05 — compared with the respective control
Figure 5. The effect of 24-hour treatment of human corneal epithelial cells with oleanolic acid (OA) and ursolic acid (UA). ELISA assay of 
MMP-2 level. The figure shows an average of three independent experiments. * p ≤ 0.05 — compared with the control
to have antiallergic properties [3] as well as being 
useful when uploaded onto nanoplatforms in an-
ti-inflammatory applications [1]. In our study we 
showed that, in principle, only oleanolic acid at 
concentrations lower than 50 µM is not toxic for 
human corneal epithelial cells. On the other hand, 
ursolic acid significantly reduced the viability of 
cells even at the lowest (5 µM) concentration used. 
These results are in agreement with literature data 
showing that UA modulates mitochondrial redox 
activity and decreases mitochondrial membrane 
potential; this results in cell cycle phase arrest and 
consequently apoptosis of cells [11, 12]. Moreover, 
UA treatment of cells may decrease the anti-apop-
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Figure 6. The effect of 24-hour treatment of human corneal epithelial cells with oleanolic acid (OA) and ursolic acid (UA). ELISA assay 
of MMP-9 level. The figure shows an average of three independent experiments. * p ≤ 0.05 — compared with the control
OA
2 3 4 5 6
UA
2 3 4 5 611
Figure 7. SDS-PAGE (gelatine zymography) analysis of metalloproteinases (MMPs) production. Lane 1 — control; lane 2 — 5 µM of the 
OA/UA; lane 3 — 10 µM of the OA/UA; lane 4 — 25 µM of the OA/UA; lane 5 — 50 µM of the OA/UA; lane 6 — 100 µM of the OA/UA
totic Bcl-2 protein level by its phosphorylation and 
degradation, but it does not affect pro-apoptotic 
Bcl-xS or Bax protein amounts. This triterpenoid 
was also found to activate Fas/FasL pathway and 
is involved in caspase cascade activation leading 
directly to apoptotic death of treated cells [12, 13]. 
In turn, OA expressed protective effects on normal 
cells against artificially induced oxidative or inflam-
matory stress. This compound stabilised mitochon-
drial membranes or decreased COX-2 and conse-
quently PGE2 production or NADPH oxidase expres - 
sion [14]. However, the activity of both UA and 
OA is dependent on the compound concentra-
tion. Lower concentrations of OA expressed mainly 
anti-proliferative effects, but with its increase 
pro-apoptotic properties were observed depending 
on the increase in its concentration [15, 16]. These 
reports confirm observations made in our study 
showing higher activity of UA compared with OA 
on corneal epithelial cells, but simultaneously the 
impact of both factors on mitochondrial metabo-
lism was stronger than cellular membrane stability 
and direct viability of cells.
In our study we found that the higher the con-
centration of triterpenoids, the higher the NOx 
level in culture medium. It is consistent with previ-
ously published results indicating that both OA and 
UA stimulate NO release by normal cells. The pro-
cess was mainly connected with the increased level 
of inducible nitric oxide synthase (iNOS) activity. 
The mechanism of such activity has been designat-
ed as taking place through NF-κB transactivation 
and calcium-independent mechanisms. Moreover, 
triterpenoids upregulated the NO accumulation in 
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a dose-dependent manner [17, 18]. These results are 
also closely connected and confirm those respecting 
apoptosis level because NO is a recognised com-
pound that induces apoptosis through changes in 
the expression of pro-apoptotic proteins like P53 or 
Bax [18].
However, there are also reports indicating that 
OA derivatives or UA may inhibit NOS activity and 
consequently decrease NO level [19, 20]. Neverthe-
less, we may also suppose that the increased level of 
NO observed in our study may be linked with the 
increased apoptotic cell death, uncoupled metabol-
ic pathways, and release of enzymes or nitrates or 
nitrites deposited in cells into the culture medium. 
Metalloproteinases classified as gelatinases 
(MMP-2 and MMP-9) are very important because 
they are able to degrade type IV collagen being the 
most significant element of extracellular matrix and 
basement membranes [21]. They are generally pro-
duced in small amounts but exhibit high proteolytic 
activity. After quantitative analysis of MMP-2 and 
MMP-9 levels we observed that OA and UA de-
crease the amounts of these proteins. These results 
are consistent with other authors’ findings indicat-
ing that these pentacyclic terpenoids significantly re-
duce the expression of metalloproteinases [21–23]. 
The mechanism of the action was defined as run-
ning through inactivation of JNK, Akt, and mTOR 
pathways or downregulation of NF-κB [2, 22, 23]. 
When zymography was performed we found that 
only the highest concentration (100 µM) of both 
OA and UA expressed gelatinolytic activity. Simi-
larly to NOx, it could be the result of the release of 
proteins from disintegrating cells undergoing ap-
optosis. This explanation is also supported by the 
lack of clearly expressed bands of MMPs activity in 
zymography performed in our study. Instead of this, 
the whole slot line showed gelatinolytic activity. 
Therefore, generally low quantities of MMP-2 and 
MMP-9 in controls and decreased amounts of these 
proteins after corneal epithelial cell incubation with 
OA and UA resulted in a very low, almost undetect-
able activity of these MMPs measured by zymog-
raphy.
On the other hand, increased activity of 
MMP-9 and MMP-2 was observed in lens epi-
thelial cells (LECs) of patients with age-related 
cataract or in aqueous humour (AH) and uvea in 
animal models [6, 7, 24]. It suggests that OA or 
UA activity decreasing MMP levels in eye tissues 
might be an interesting alternative in the treatment 
of ocular diseases. The choice of the compound 
is also important, and our research indicates that 
OA may be more useful than UA due to lower 
concentrations needed to achieve the desired effect. 
However, further studies are needed to exclude the 
eventual toxic activities of these triterpenoids or 
to determine their effective doses for treatment of 
certain eye tissues.
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